Nuon has established a management team experienced in developing and commercializing new medicines.
Lee Rauch – President and Chief Executive Officer
- Previously Acting Head of Corporate Development, Onyx Pharmaceuticals, Inc.
- Previously Chief Business Officer, Point Biomedical, Inc.
- Previously Chief Business Officer, Onyx Pharmaceuticals, Inc.
- Previously Senior Vice President, Corporate Development, COR Therapeutics, Inc.
- Previously Partner, Mitchell Madison Group
- Previously Vice President, Strategic Marketing, Syntex Corporation
- Previously Engagement Manager, McKinsey & Company
Paulette Dillon – Chief Business Officer
- Previously Senior Vice President, Chief Business Officer, Anacor Pharmaceuticals, Inc.
- Previously Senior Vice President, Chief Business Officer, Avidia, Inc. (acquired by Amgen)
- Previously Vice President ,Chief Business Officer Celera Genomics, Inc.
- Previously Vice President, Market and Business Development, Exelixis, Inc.
- Previously Vice President, Strategic Market and Business Development, Roche (previously Syntex)
Helen Jenkins, M.A. – Chief Operating Officer
- Previously SVP, Development Operations, Saegis Pharmaceuticals
- Previously Sr. Director, Product Development, Regulatory Affairs, Valentis
- Previously Project Manager, Glycomed Inc. and Genentech, Inc.
Michael Kitt, M.D. – Chief Medical Officer
- Previously Senior Vice President, Development, Theravance Inc.
- Previously Vice President, Clinical Research, COR Therapeutics
- Previously Senior Vice President, Clinical Research, Sterling Winthrop
- Previously Vice President, International Clinical Research, the Upjohn Company
Tito Serafini, Ph.D. – Chief Scientific Officer
- Previously Co-Founder and Vice President, Renovis, Inc.
- Previously Faculty, Department of Molecular and Cell Biology,
UC Berkeley - Postdoctoral fellowship, UCSF
- Ph.D. in Biochemistry, Stanford